![Patrick Norman Bergstedt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick Norman Bergstedt formerly worked at PT Organon Pharma Indonesia Tbk, as President Commissioner, Merck Sharp & Dohme Asia Pacific Services Pte Ltd., as President from 2001 to 2020, and Moderna, Inc., as Senior Vice President-Commercial Vaccines.
Mr. Bergstedt received his undergraduate degree from the University of Johannesburg.
| Unternehmen | Position | Ende |
|---|---|---|
Merck Sharp & Dohme Asia Pacific Services Pte Ltd.
 Merck Sharp & Dohme Asia Pacific Services Pte Ltd. Medical DistributorsDistribution Services Wholesales pharmaceutical products | Präsident | 01.05.2020 |
| MODERNA, INC. | Corporate Officer/Principal | - |
| MERCK SHARP DOHME PHARMA TBK PT | Vorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
PT Organon Pharma Indonesia Tbk
 PT Organon Pharma Indonesia Tbk Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical and healthcare products | Health Technology |
University of Johannesburg
 University of Johannesburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Sharp & Dohme Asia Pacific Services Pte Ltd.
Merck Sharp & Dohme Asia Pacific Services Pte Ltd. Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
